Sector Chart Summit Therapeutics Inc.

Stocks

SMMT

US86627T1088

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 16:00:00 2026-07-07 EDT			After hours 20:00:00
15.88 ^USD	-0.31%		21.43	+34.95%

06-22	Analyst recommendations: Accenture, Conocophillips, Diamondback Energy, Oracle, Applied Materials…
06-12	Summit Therapeutics Insider Bought Shares Worth $49,987,200, According to a Recent SEC Filing	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Bio Therapeutic Drugs

	Capi.	Sales Growth	Profitability	Finances	EV / Sales	P/E
SUMMIT THERAPEUTICS INC.	12.33B	-	-	-	-	-
ARGENX SE	57.72B
WUXI APPTEC CO., LTD.	52.65B
INSMED INCORPORATED	24.46B					-
BIONTECH SE	23.84B					-
WUXI BIOLOGICS (CAYMAN) INC.	19.28B